AN ADAPTIVE HEALTHCARE SOLUTIONS COMPANY

OTC: PLSI

AN ADAPTIVE HEALTHCARE SOLUTIONS COMPANY

OTC: PLSI

LEARN MORE

VISION

Create a future where the human  body can repair, restore, and  rejuvenate itself.

MISSION

Create a global platform for the reintroduction of plant based pharmaceuticals, including medical cannabis products into the mainstream of healthcare.

WHO IS PHOENIX LIFE?

A global platform for the re-introduction of organic, plant based pharmaceuticals and programs for creating healthcare solutions and reducing total cost of national healthcare programs

A global platform for the reintroduction of medical cannabis products into the mainstream of healthcare.

Our business is to advance research and integrate programs and manufacturing of products that target and treat; diabetes, pain, cancers, and address psychological, gastrointestinal, autoimmune, neurological and sleep disorders.

Creating partnerships for integrating these programs for human health into communities worldwide as part of our Global Health Initiative. Working with developing nations on programs to improve affordable healthcare and creating industry.

Phoenix Life Sciences uses organically produced plants, including cannabis, extracts the purist of active ingredients
and encapsulates them for maximum bio availability and efficacy. Providing a patient-centric alternative to the
low efficacy and the high side effects of conventional pharmaceuticals.

Giving doctors and their patients an easy to take, easy to manage, accurately dosed natural healthcare solution.

Phoenix Life Sciences International is targeting to build production to service over 2.5 million patients over the next 5 years.

Distribution

OVERVIEW

Phoenix Life Sciences International Limited is headquartered in Denver, Colorado. Over the past four years, many of our partner organizations have worked hard to develop and access a broad range of industry and pharmacology specialists. The partnership includes botanists, biologists, industrial and organic chemists, medical doctors, researchers, packagers and distributors. We are delighted to announce that in September 2018 we merged many of these partnerships and affiliations together under the name Phoenix Life Sciences International Limited. Without the support and collaboration of many individuals, this vision wouldn’t have been realized and we thank them for their global vision.

Sign Up for E-Mail Alerts


By submitting this form, you are consenting to receive marketing emails from: Phoenix Life Sciences International Limited, 3000 Lawrence Street, Denver, CO, 80205, http://www.phoenixlife.co. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Sign Up for E-Mail Alerts

Latest News

JOIN THE GLOBAL HEALTH INITIATIVE

Corporate Videos

Contacts

Public Relations Contact:

CMW Media
Kathryn Reinhardt, 858-264-6600
kathryn@cmwmedia.com
www.cmwmedia.com

Investor Relations Contact:

+1.888.717.5655

investor.relations@phoenixlife.co

Transfer Agent Contact:

Clear Trust
16540 Pointe Village Dr, Suite 205 Lutz, Florida 33558
Phone 813.235.4490
Fax 813.388.4549

Disclaimers

Securities Law Disclaimer

The information contained herein has been prepared for informational purposes and is not an offer to buy or sell or a solicitation of an offer to buy or sell any security or to participate in an investment strategy. Any offering of securities shall be pursuant to a definitive Private Placement Memorandum and Subscription Agreement, which may supersede this information in its entirety. This information is intended to be distributed to and viewed only by Accredited Investors as defined by the Securities Act of 1933.

Forward Looking Statements

This presentation contains forecasts of prospective financial information that have been prepared on the basis of assumptions as to future events which management expects to take place and the actions management expects to take as of the date the information is prepared. Past performance may not be indicative of future results. Therefore, no current or prospective investor should assume that the future performance of any specific investment, investment strategy, or product made reference to directly or indirectly in this document, or indirectly via link to any unaffiliated third-party website, will be profitable or equal to corresponding indicated performance levels.

FDA Disclaimer

The statements contained herein regarding cannabinoids and treatment options are made based on clinical research of various U.S. approved conditions for cannabis use. These statements have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products have not yet been approved by the FDA to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from healthcare practitioners.